Chris Murphy actually said...

"I think I share some of the sentiments that Senator Cardin has expressed regarding what is a hard-fought and hard-won compromise, but a compromise first, second, and third."

"We talked about the certainty that the industry needs to start populating the field with more biosimilars."

"Thank you, Mr. Chairman."

"These reductions will result in significant savings to the healthcare system and patients as the biosimilar market matures."